Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial-Reference-Cited by-同舟云学术

Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial

Published:2018-02 Issue:2 Volume:5 Page:e68-e78
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Bekker Linda-Gail,Roux Surita,Sebastien Elaine,Yola Ntando,Amico K Rivet,Hughes James P,Marzinke Mark A,Hendrix Craig W,Anderson Peter L,Elharrar Vanessa,Stirratt Michael,Rooney James F,Piwowar-Manning Estelle,Eshleman Susan H,McKinstry Laura,Li Maoji,Dye Bonnie J,Grant Robert M

Funder

HIV Prevention Trials Network

HPTN Laboratory Centre

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference34 articles.

1. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;N Engl J Med,2012

2. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med,2010

3. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana;Thigpen;N Engl J Med,2012

4. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection;Molina;N Engl J Med,2015

5. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial;McCormack;Lancet,2016

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial;AIDS and Behavior;2024-07-31

2. PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice;Current HIV/AIDS Reports;2024-07-24

3. Breakthrough Acute HIV Infections among Pre-Exposure Prophylaxis Users with High Adherence: A Narrative Review;Viruses;2024-06-12

4. Pre-exposure Prophylaxis for Transgender People: A Systematic Review;Clinical Infectious Diseases;2024-04-24

5. Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies;Clinical Infectious Diseases;2024-03-14